An affiliate of private equity investment firm HIG Capital has completed the acquisition of American Pacific Corporation (AMPAC), a manufacturer of fine and specialty chemicals, in a take private transaction.
Headquartered in Las Vegas, NV, the Company operates under two primary business segments. The Fine Chemicals segment is a market leader in the manufacture of pharmaceutical ingredients, including active pharmaceutical ingredients and registered intermediates. The Specialty Chemicals segment is the sole North American producer of ammonium perchlorate, the mission-critical oxidising agent for solid propellant rockets, booster motors and missiles used in government and commercial aerospace and defence programs.
Joe Carleone, CEO of AMPAC, says: "We are very excited about this next stage for AMPAC. Our partnership with HIG provides us with financial and operating resources that will enable us to further capitalise on market opportunities and to realize our significant growth potential."
"We are pleased to support Joe and his team in their growth and says Fraser Preston, a Managing Director of HIG "AMPAC is a market leader with a long track record of delivering custom, high-quality products, utilising difficult chemistries and specialized equipment and processes. We look forward to helping AMPAC further enhance its technology platform and production and service capabilities.”
Financing for the transaction was provided by Jefferies LLC and Credit Suisse Securities (USA) LLC.
